@MrAwesome what is it that other companies are doing while listed that we aren't exactly?
From the quarterlies that were just released CGB generated more revenue in suspension than AC8 and CAN put together.
Just because a company is trading dosen't mean that it is doing well. To be honest I can't see half of the listed ASX MM companies ever turning a profit. For many it has been hype built around "oh we have this license" "we have this government connection" " we have this consultant on the BOD " etc. Those days are over, its now about turn a profit or get out.
Over the next 12 to 24 months I am of the belief that we will see many companies be acquired for their IP or licenses or simply deregister from the ASX.
CGB is generating revenue, even though it isn't currently a profit it is far more than 90% of the other ASX MM companies.
If this partnership with Biohealth is a success as management are suggesting then by the end of this year we will have generated more profit than all our competitors with maybe the exception of EXL.
